Lataa...
Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia
Imatinib, a tyrosine kinase inhibitor, is well known to cause hypopigmentation because of its inhibitory effect on melanocytes. Herewith we report a case of chronic myeloid leukemia who developed extensive hyperpigmentation following imatinib therapy.
Tallennettuna:
| Julkaisussa: | Indian J Dermatol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4601460/ https://ncbi.nlm.nih.gov/pubmed/26538739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5154.164447 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|